Usv Limited

About Us

We are a leading healthcare company with the following areas of focus: Generics, Active Pharmaceutical Ingredients (APIs) and Biosimilars. 68% of our business is contributed by India Operations and the rest by export of APIs and Generics.

USV is a 48 year old healthcare company which began as a joint venture with USV&P Inc, a subsidiary of Revlon.

Our product range consists of Generics, Active Pharmaceutical Ingredients and Biotherapeutics that are manufactured in our modern cGMP compliant plants located in India.

We market our products globally to over 40 countries. In financial year 2008-09 our sales were Rs. 8,451 million.

Our Indian business contributes to 68% of our sales. In India we are recognized for our leadership in the area of Diabetes where we are leaders by Rx and Value in the oral segment. In the Cardiovascular segment we are No 1 by Rx and in the top 10 by Value. We also have significant presence with leading brands in areas of Gynaecology, Dermatology, Gastroenterology and General Practice.

Our international business contributes 32% to our sales. The product portfolio for international markets consists of:

• A large portfolio of small molecule APIs. Of the 52 products in our portfolio, 23 APIs are commercially available with others in various stages of development. Our special skills include production and characterization of polymorphs and particle sizing
• A portfolio of 34 solid oral finished products that span immediate release, modified release and products with 'complex' characteristics.
• A portfolio of 17 injectables and ophthalmic products based on small molecules.
• A portfolio of 4 rDNA based Biosimilars or Follow-on-Biologics.

Our spend of 8-9% of sales on R&D ensures that we are able to deliver on our research portfolio. We have over 100,000 sq. ft. of laboratory space with excellent infrastructure and driven by a team of 246 scientists including 32 PhDs, many who have been trained in universities in USA, Europe and Japan. Our intellectual property portfolio consists of 77 international patent filings with 24 grants.

We see a bright future for USV in the coming years. We provide an environment that values people, promotes learning, nurtures innovation and rewards excellence.